肠道葡萄糖吸收调节的进展,以改善动物的能量效率
Yan Ye1, Xiongfei Zhang1, Junhu Yao1
1College of Animal Science and Technology, Northwest A&F University, Yangling 712100, China.
Animals : an open access journal from MDPI
|February 27, 2026
概括
食动物与肠道葡萄糖吸收作斗争,限制了能源效率. 本综述探讨了通过饮食,微生物群和人工甜味剂等新策略来增强葡萄糖吸收,以改善反动物营养.
科学领域:
- 动物的营养和新陈代谢
- 胃肠道生理学 胃肠道生理学
背景情况:
- 高谷物饮食会导致粉绕过小肠发酵,进入小肠.
- 食动物在小肠中粉水解和葡萄糖运输的能力有限.
- 改善肠道葡萄糖吸收是提高反动物能量效率的关键.
研究的目的:
- 审查影响反动物肠道葡萄糖吸收的因素.
- 探索在小肠中感知和运输葡萄糖的机制.
- 确定改善葡萄糖吸收和反动物能量利用的策略.
主要方法:
- 系统审查有关饮食,本体生理,环境和微生物群影响的文献.
- 分析葡萄糖感应 (T1R2/T1R3) 和输送途径.
- 评估各种体外和体内方法来评估葡萄糖吸收.
- 讨论包括人工甜味剂和GLP-2调节在内的潜在策略.
主要成果:
- 肠道葡萄糖吸收受饮食,年龄,环境和肠道微生物群的影响.
- 特定的葡萄糖感应和运输通路对于吸收效率至关重要.
- 在研究葡萄糖吸收方面,各种实验方法都有局限性和优势.
- 功能性氨基酸可以增强胰腺α-氨基酶,但葡萄糖吸收策略的探索较少.
结论:
- 增强小肠的葡萄糖吸收提供了一个有前途的途径,以提高反动物的能源效率.
- 针对葡萄糖感应通路,运输机制和激素调节 (例如GLP-2) 是关键策略.
- 对人工甜味剂和其他调节剂的进一步研究可以优化反动物的营养.
更多相关视频
相关概念视频
Glucose Absorption Into the Small Intestine
36.5K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
36.5K
Carbohydrate Absorption
6.8K
Carbohydrates are essential macronutrients that serve as the body's primary energy source. Their digestion begins in the mouth, where salivary amylase partially breaks down complex carbohydrates such as starch into smaller oligosaccharides. This mechanical and enzymatic activity prepares carbohydrates for further processing in the gastrointestinal tract.
After being swallowed, the partially digested carbohydrates mix with gastric secretions in the stomach. However, the acidic environment...
After being swallowed, the partially digested carbohydrates mix with gastric secretions in the stomach. However, the acidic environment...
6.8K
Glucose Transporters
27.8K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.8K
Glucagon-like Receptor Agonists
1.1K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.1K
Transcellular Transport of Solutes
4.9K
Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
4.9K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
672
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
672


